4//SEC Filing
Horizon Pharma plc 4
Accession 0001209191-15-029409
CIK 0001492426operating
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 9:48 PM ET
Size
10.8 KB
Accession
0001209191-15-029409
Insider Transaction Report
Form 4
Kelly David George
EVP & Corporate Secretary
Transactions
- Award
Performance Share Units (PSU)
2015-03-23+186,000→ 186,000 total→ Ordinary Shares (186,000 underlying) - Award
Stock Option (Right to Buy)
2015-03-23+173,000→ 173,000 totalExercise: $22.14Exp: 2025-03-22→ Ordinary Shares (173,000 underlying) - Award
Restricted Stock Units
2015-03-23+77,000→ 77,000 total→ Ordinary Shares (77,000 underlying)
Footnotes (4)
- [F1]25% of the shares subject to the option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F3]The restricted stock units vest 25% annually on each anniversary of the date of grant.
- [F4]Each PSU represents a contingent right to receive ordinary shares of the Issuer, based on the Issuer's level of total shareholder return, as measured on December 22, 2017, March 22, 2018 and June 22, 2018 or based on the level of total shareholder return through any earlier change in control. For such purposes, total shareholder return means the percentage change in the price of the Issuer's ordinary shares on a compounded annual basis, plus the value of reinvested dividends. The number of shares issued may range from zero (0) shares to the maximum number of shares reported in columns 7 and 9 of this report.
Documents
Issuer
Horizon Pharma plc
CIK 0001492426
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001492426
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 9:48 PM ET
- Size
- 10.8 KB